AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer

NCT04993391 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: JS111(AP-L1898 Capsules)
DRUG: JS111(AP-L1898 Capsules)
DRUG: JS111(AP-L1898 Capsules)
DRUG: JS111(AP-L1898 Capsules)
DRUG: JS111(AP-L1898 Capsules)

Sponsor

Suzhou Junjing BioSciences Co., Ltd.